Dentons US LLP

01/13/2025 | News release | Distributed by Public on 01/13/2025 05:19

Hankyung Bio Insight January 2025: FDA’s Latest Thinking on Accelerated Approval Program for Drugs and Biologics by Bernard K. Ham

January 13, 2025

Foreign Senior Attorney Bernard K. Ham contributed an article titled "FDA's Latest Thinking on Accelerated Approval Program for Drugs and Biologics" to the January issue of Hankyung Bio Insight.

Please follow the link below to access the article.

The attached file: 120-125 Global Lifescience Regulatory Development.pdf

Hankyung Bio Insight delivers the latest business information and industry trends of domestic and international pharmaceutical, bio, and healthcare companies. In addition, it provides in-depth investment information through CEO interviews, company visits, and pipeline analyses.